Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

GF80461964

Magnesium

microleaf, 25x25mm, thinness 1.0μm, specific density 174μg/cm2, removable support, 99.9%

Synonym(s):

Magnesium, MG004990

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
Mg
CAS Number:
7439-95-4
Molecular Weight:
24.31
Beilstein:
4948473
MDL number:
MFCD00085308
UNSPSC Code:
12141502
PubChem Substance ID:
329812053
NACRES:
NA.23

vapor pressure

1 mmHg ( 621 °C)

Assay

99.9%

form

sheet (microleaf)

autoignition temp.

950 °F

manufacturer/tradename

Goodfellow 804-619-64

resistivity

4.46 μΩ-cm, 20°C

size × thickness

25 x 25 mm × 1.0 μm

bp

1090 °C (lit.)

mp

648 °C (lit.)

density

1.74 g/mL at 25 °C (lit.)

SMILES string

[Mg]

InChI

1S/Mg

InChI key

FYYHWMGAXLPEAU-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Pictograms

Flame
GHS02

Signal Word

Warning

Hazard Statements

H228

Hazard Classifications

Flam. Sol. 2

Storage Class Code

4.1B - Flammable solid hazardous materials

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Wei Yang
Biochemistry, 53(17), 2793-2803 (2014-04-11)
Y-Family DNA polymerases specialize in translesion synthesis, bypassing damaged bases that would otherwise block the normal progression of replication forks. Y-Family polymerases have unique structural features that allow them to bind damaged DNA and use a modified template base to
Charles L Loprinzi et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(10), 997-1005 (2013-12-04)
Cumulative neurotoxicity is a prominent toxicity of oxaliplatin-based therapy. Intravenous calcium and magnesium have been extensively used to reduce oxaliplatin-induced neurotoxicity. This trial was designed to definitively test whether calcium/magnesium decreases oxaliplatin-related neurotoxicity. In all, 353 patients with colon cancer
Parisa Asghari et al.
Circulation research, 115(2), 252-262 (2014-05-03)
Single-tilt tomograms of the dyads in rat ventricular myocytes indicated that type 2 ryanodine receptors (RYR2s) were not positioned in a well-ordered array. Furthermore, the orientation and packing strategy of purified type 1 ryanodine receptors in lipid bilayers is determined
H Gulliksson
Vox sanguinis, 107(3), 205-212 (2014-07-01)
Present platelet storage media often designated platelet additive solutions (PAS) basically contain acetate, citrate and phosphate and recently also potassium and magnesium. However, there seems to be an increasing interest in developing PASs that can be used also after further
Sara Castiglioni et al.
Nutrients, 5(8), 3022-3033 (2013-08-06)
A tight control of magnesium homeostasis seems to be crucial for bone health. On the basis of experimental and epidemiological studies, both low and high magnesium have harmful effects on the bones. Magnesium deficiency contributes to osteoporosis directly by acting
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service